|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 04740230.0 (espacenet) (Federated) (European Patent Register), 20040622 | | Patent/reg. no. and date | DK/EP 1641787, 20070502 | | Publication date | 20060405 | | Priority no. and date | GB 0314738, 20030624 | | EP pub. no. and date |
EP 1641787 20060405 | | Effective date | | | Applicant/owner | Glaxo Group Limited, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | | Applicant ref. no. | P80703038DK00E | | Inventor | LIDDLE, John
GlaxoSmithKline, Gunnels Wood Road
Stevenage
Hertfordshire SG1 2NY, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , C07D 413/06 (2006.01) | | Title | Substituerede diketopiperaziner og deres anvendelse som oxytocinantagonister | | Int. application no. | EP2004006814 | | Int. publication no. | WO2005000840 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
